RKIP: much more than Raf kinase inhibitory protein

Related Experiment Video

Updated: May 14, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Fahd Al-Mulla1, Milad S Bitar, Zainab Taqi

  • 1Faculty of Medicine, Department of Pathology, Kuwait University Health Sciences Centre, Safat, Kuwait. fahd@al-mulla.org

Journal of Cellular Physiology
|January 30, 2013
PubMed

Insights

RKIP, a critical regulator of cellular responses, is vital in preventing diseases like cancer. Understanding its role offers new therapeutic strategies for various pathologies.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Biochemistry

Background:

  • Raf Kinase Inhibitor Protein (RKIP) was initially identified as a phosphatidylethanolamine-binding protein.
  • RKIP functions as a physiological inhibitor of the Raf kinase protein, playing a key role in cellular signaling pathways.
  • Dysregulation of RKIP is implicated in numerous pathologies, including cancer, Alzheimer's disease, and pancreatitis.

Purpose of the Study:

  • To review recent advancements in RKIP research.
  • To underscore RKIP's potential as a master modulator of intracellular signaling cascades.
  • To highlight biological and functional niches for future research.

Main Methods:

  • Literature review of recent studies on RKIP.
  • Analysis of RKIP's role in cellular processes such as growth, motility, and apoptosis.
  • Examination of RKIP's involvement in genomic integrity and therapeutic resistance.

Main Results:

  • RKIP is crucial for maintaining controlled cellular responses to stimuli.
  • RKIP's disruption is linked to significant diseases, positioning it as a therapeutic target.
  • RKIP modulates pivotal signaling pathways controlling cell growth, motility, apoptosis, genomic integrity, and drug resistance.

Conclusions:

  • RKIP is a key regulator of cellular signaling with broad implications in health and disease.
  • Targeting RKIP presents a promising avenue for individualized and disease-specific therapies.
  • Further research into RKIP's diverse roles is essential for developing effective interventions.

More Related Videos

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells06:44

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells

Published on: March 1, 2024

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...